- Journal Archives
- Volume 17
- Volume 16
- Volume 15
- Volume 14
- Volume 13
- Volume 12
- Volume 11
- Volume 10
- Volume 9
- Volume 8
- Volume 7
- Volume 6
- Volume 5
- Volume 4
- Volume 3
- Volume 2
- Volume 1
Currently viewing the tag: "drug testing"
In 2008, two Minnesota Vikings defensive linemen (Kevin and Pat Williams) received four game suspensions for violating the NFL’s drug policy. The players tested positive for Bumetanide, a substance that can help to mask steroids. Both players attributed the positive test to the weight loss supplement StarCaps. The players appealed and the appeals were [...]Continue Reading →
In the news . . .
New Orleans Saints’ quarterback Drew Brees weighs in on the Supreme Court’s upcoming hearing in American Needle v. NFL.
NBA Commissioner David Stern hands down indefinite suspension for the Wizards’ Gilbert Arenas amidst gun investigation. Meanwhile, one University of Tennessee player involved in drug and firearms [...]Continue Reading →
On December 3, 2009 By Andrew Cunningham July 24, 2010
Although the MLB season ended almost a month ago, and many fans have since directed their full attention to other professional and college sports, for me, the offseason is where the magic happens. Since my Philadelphia Phillies fell just short of glory, I have been recurringly checking for a holiday miracle signing at third base. [...]Continue Reading →
Bill Simmons, the popular writer for ESPN.com, recently discussed the continual leaking of information regarding steroid use in baseball in the early 2000s and compared this lingering phenomenon to, among other less savory things, an automatic debit that just cannot be canceled. The description is apt for a somewhat beguiling situation [...]Continue Reading →
Recent Blog Posts
- Neiman Marcus Shoppers Suffer Financial Injuries! Possibly
- Facebook Gears up for Trademark Fight With Brazilian Competitor
- Draft Kings: A fantasy sports betting website valued close to $1 Billion
- Are Design Patents Really a Wise Investment Now?
- The Door Left Ajar: Navigating the Patent-Antitrust Paradox in Light of King Drug Co. v. GlaxoSmithKline
- Will Feds Preempt Tougher State Data Breach Laws?
Tagsadvertising antitrust Apple books career celebrities contracts copyright copyright infringement courts creative content criminal law entertainment Facebook FCC film/television financial First Amendment games Google government intellectual property internet JETLaw journalism lawsuits legislation media medicine Monday Morning JETLawg music NFL patents privacy progress publicity rights radio social networking sports Supreme Court of the United States (SCOTUS) technology telecommunications trademarks Twitter U.S. Constitution